Mag-aso, Edsel S.

HRN: 19-68-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CEFTRIAXONE 1G (VIAL)
06/06/2022
06/12/2022
IV
2gm
Q24
Uti
Waiting Final Action 
06/14/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/14/2022
06/21/2022
IVTT
2.25g
Q8h
Liver Infection
Waiting Final Action 
06/16/2022
RIFAXIMIN 200MG (TAB)
06/16/2022
06/23/2022
PO
200mg
BID
Imperical Escalation
Waiting Final Action 
09/03/2022
CEFTRIAXONE 1G (VIAL)
09/03/2022
09/09/2022
IV
1g
BID
T/C Spontaneous Bacterial Peritonitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: